2017-11-15T12:49:41-06:00 2016-12-31 721473527 HIENZ & MACALUSO LLC 110 VETERANS BLVD SUITE 170 METAIRIE LA 70005 990 2016-01-01 471643994 ANSWER ALS ANSW 8004902375 ONE GALLERIA BLVD NO 1100 METAIRIE LA 70001 PAUL VARISCO DIRECTOR 8004902375 2017-11-13 1 ROBERT W HIENZ P00751267 5048375434 2017-11-13 199.227.118.181 2017-11-13 11:42:21 CS P 96D5DC4BC275B2A5273F262BDBCAA839C18D6EDE 485894E2D1E84DE458AB5B65F65876DDA6D68FD6 2016 2021-01-29 14:40:06Z PAUL VARISCO ONE GALLERIA BLVD NO 1100 METAIRIE LA 70001 1142342 0 X WWW.ANSWERALS.ORG X 2014 LA TO FIND SOLUTIONS FOR PEOPLE LIVING WITH ALS NOW AND FOR THE FUTURE BY UTILIZING KNOWLEDGE OF PATIENTS, LEADING RESEARCHERS AND TECHNOLOGY TO SEEK IMMEDIATE SOLUTIONS TO IMPROVE THE LIVES OF THOSE LIVING WITH ALS UNTIL A TREATMENT OR CURE IS FOUND; DISCOVER WHAT CAUSES ALS; DEVELOP MODELS TO UNDERSTAND ALS AND SCREEN FOR DRUG AND CELLULAR THERAPY; DISCOVER THERAPIES THAT COULD SUBSTANTIALLY SLOW OR HALT THE PROGRESS OF ALS AND ULTIMATELY CURE THE DISEASE; PROVIDE ALL GATHERED INFORMATION FREE FOR WORLDWIDE USE BY CLINICIANS, SCIENTISTS AND PHARMA TO RAPIDLY ADVANCE THERAPEUTICS. 3 3 0 6 0 0 440835 1142342 0 0 0 0 -1892 0 438943 1142342 0 135000 0 0 0 0 0 0 50122 158679 136323 158679 271323 280264 871019 280264 1151283 0 0 280264 1151283 X TO FIND SOLUTIONS FOR PEOPLE LIVING WITH ALS NOW AND FOR THE FUTURE BY UTILIZING KNOWLEDGE OF PATIENTS, LEADING RESEARCHERS AND TECHNOLOGY TO SEEK IMMEDIATE SOLUTIONS TO IMPROVE THE LIVES OF THOSE LIVING WITH ALS UNTIL A TREATMENT OR CURE IS FOUND; DISCOVER WHAT CAUSES ALS; DEVELOP MODELS TO UNDERSTAND ALS AND SCREEN FOR DRUG AND CELLULAR THERAPY; DISCOVER THERAPIES THAT COULD SUBSTANTIALLY SLOW OR HALT THE PROGRESS OF ALS AND ULTIMATELY CURE THE DISEASE; PROVIDE ALL GATHERED INFORMATION FREE FOR WORLDWIDE USE BY CLINICIANS, SCIENTISTS AND PHARMA TO RAPIDLY ADVANCE THERAPEUTICS. 0 0 206648 135000 CREATING THE LARGEST AND MOST COMPREHENSIVE FOUNDATION OF ALS DATA EVER AMASSED, ENCOMPANSING CLINICAL, CHEMICAL, GENETIC, PROTEIN, HISTORICAL AND BIOLOGICAL DATA FROM AN ENORMOUS SAMPLING OF ALS PATIENTS IN THE UNITED STATES. IN COLLABORATION WITH MACHINE LEARNING AND BIG DATA TECHNOLOGY, THE DATA WILL BE MINED TO UNCOVER ALS CAUSES, SUBTYPES,PATHWAYS GONE AWRY AND DRUG TARGETS. THIS WILL ESTABLISH A LARGE AND CRITICAL FOUNDATION FOR NEW CLINICAL TRIALS, DEVELOP NEW WAYS TO CATEGORIZE PATIENTS TO IDENTIFY SPECIFIC DRUGGABLE PATHWAYS AND SUBTYPE BIOMARKERS AND DISEASE PATHOPHYSIOLOGY TO AID NOT ONLY IN EARLY DIAGNOSIS OF THE DISEASE, BUT ALSO TO MONITOR THE EFFICACY OF NEWLY DEVELOPED TREATMENTS. 206648 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 3 3 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 0 0 0 X THE ORGANIZATION 8004902375 ONE GALLERIA BLVD NO 1100 METAIRIE LA 70001 PAUL VARISCO DIRECTOR 5.00 X X 0 0 0 TOM CAPELLA SECRETARY 2.00 X X 0 0 0 CLAIRE DURRETT BOARD MEMBER 20.00 X 21000 0 0 21000 0 0 0 0 0 0 0 1142342 1142342 1142342 0 0 0 135000 135000 1500 1500 22952 7000 7000 8952 13225 4364 8861 1841 821 609 411 1006 1006 23198 15558 3000 4640 28387 25548 2839 WEBSITE MAINTENANCE 21413 14989 6424 OTHER FUNDRAISING 11605 11605 MISCELLANEOUS 6244 3368 1438 1438 CREDIT CARD PROCESSING 4952 4952 271323 206648 14553 50122 199835 1099106 80429 52042 0 135 280264 1151283 0 0 X 651283 280264 500000 280264 1151283 280264 1151283 871019 0 X 0 0 0 X 440835 1142342 1583177 440835 1142342 1583177 573344 1009833 1583177 X SCHEDULE A PART II LINE 13 THE ORGANIZATIONS FIRST YEAR STARTED AUGUST 20, 2014 EFFECTIVE DATE OF EXEMPTION. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 CENTER FOR MEDICARE ADVOCACY 11 LEDGEBOOK DRIVE MANSFIELD CENTER CT 06250 25000 HELP PEOPLE WITH DISABILITIES OBTAIN FAIR ACCESS TO MEDICARE AND QUALITY HEALTH CARE. ROBERT PACKARD CENTER FOR ALS RESEARCH JOHN HOPKINS UNIVERSITY SCHOOL OF ME 855 NORTH WOLFE STREET RM 270 BALTIMORE MD 21205 110000 ASSIST IN ALS RESEARCH. FORM 990, PART VI, SECTION B, LINE 11B A COPY OF THE ORGANIZATION'S FORM 990 WILL BE PROVIDED TO THE ORGANIZATION'S GOVERNING BODY FOR REVIEW PRIOR TO IT BEING FILED. FORM 990, PART VI, SECTION B, LINE 12C THE BOARD REVIEWS AND ENFORCES COMPLIANCE WITH THE CONFLICT OF INTEREST POLICY. FORM 990, PART VI, SECTION C, LINE 19 NO DOCUMENTS ARE PROVIDED TO THE GENERAL PUBLIC. GLEASON INITIATIVE FOUNDATION PO BOX 24493 NEW ORLEANS LA 70124 453689316 SEE PART VII FOR DESCRIPTION LA 501(C)(3) LINE 7 N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0